Literature DB >> 3172095

The prevalence of Behçet's syndrome in a rural area in northern Turkey.

S Yurdakul1, I Günaydin, Y Tüzün, N Tankurt, H Pazarli, Y Ozyazgan, H Yazici.   

Abstract

We conducted a field survey to establish the prevalence of Behçet's syndrome among all the inhabitants aged 10 years or older in a village in northern Turkey. The prevalence of Behçet's syndrome was 19/5,131. There were 13 females and 6 males. None had eye involvement. Pathergy test was positive in 6/18 (33%) and 5/19 carried HLA-B5 (26%), suggesting that the previously established association of HLA-B5 in Behçet's syndrome is mainly true for hospital based populations. Moreover, the pathergy test was less commonly positive in milder disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3172095

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  48 in total

Review 1.  Pulmonary manifestations of Behçet's disease.

Authors:  F Erkan; A Gül; E Tasali
Journal:  Thorax       Date:  2001-07       Impact factor: 9.139

Review 2.  Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51.

Authors:  H Direskeneli
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

3.  Prevalence and patterns of neurological involvement in Behcet's disease: a prospective study from Iraq.

Authors:  A Al-Araji; K Sharquie; Z Al-Rawi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-05       Impact factor: 10.154

4.  Arthropathy, quality of life, depression, and anxiety in Behcet's disease: relationship between arthritis and these factors.

Authors:  Ali Gur; Aysegul Jale Sarac; Yahya Kemal Burkan; Kemal Nas; Remzi Cevik
Journal:  Clin Rheumatol       Date:  2006-04-26       Impact factor: 2.980

5.  Behçet's disease.

Authors:  B Wechsler; J C Piette
Journal:  BMJ       Date:  1992-05-09

6.  Prevalence of Behcet's disease among adult patients consulting three major clinics in a Druze town in Israel.

Authors:  Pinchas Klein; Abraham Weinberger; Vered Jean Altmann; Salim Halabi; Saeed Fachereldeen; Ilan Krause
Journal:  Clin Rheumatol       Date:  2010-05-14       Impact factor: 2.980

Review 7.  Behçet's syndrome.

Authors:  Yusuf Yazici; Sebahattin Yurdakul; Hasan Yazici
Journal:  Curr Rheumatol Rep       Date:  2010-12       Impact factor: 4.592

8.  Primary association of HLA-B51 with Behçet's disease in Ireland.

Authors:  D J Kilmartin; A Finch; R W Acheson
Journal:  Br J Ophthalmol       Date:  1997-08       Impact factor: 4.638

Review 9.  Practical treatment recommendations for pharmacotherapy of Behçet's syndrome.

Authors:  H Yazici; C G Barnes
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

10.  Paroxysmal dysarthria and ataxia in a patient with Behçet's disease.

Authors:  F G Akman-Demir; M Eraksoy; I H Gürvit; G Saruhan-Direskeneli; O Aral
Journal:  J Neurol       Date:  1995-05       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.